Rethinking Pain Relief: Multimodal Strategies and Safer Opioid Prescribing for APPs, Rachel McMinn, RN, MSN, APNP-BC & Laura Sasse, RN

Series Overview

APP Grand Rounds works to provide continuing education for Advanced Practice Providers. Sessions will focus on evaluation and management of acute and chronic diseases across the lifespan as well as professional development topics. Presenters are asked to provide opportunities for learner engagement including case studies, pre/post quizzes, and interactive learning modalities. 

Intended Audience

MD/DO, RN, APRN, Physician Assistants, Certified Registered Nurse Anesthetists, Anesthesiologist Asisstants, and Students

Learning Objectives

As a result of participation in this educational activity, members of the healthcare team will be able to:

  1. Define types of pain and pain assessments
  2. Summarize non-opioid pharmacological strategies
  3. Develop safer opioid management strategies
  4. Discuss considerations for special populations
  5. Summarize non-pharmacological strategies
Course summary
Available credit: 
  • 1.00 AAPA Category 1 CME
    • 1.00 Wisconsin Responsible Opioid Prescribing Credit
  • 1.00 AMA PRA Category 1 Credit
    • 1.00 Wisconsin Responsible Opioid Prescribing Credit
  • 1.00 ANCC Contact Hours
    • 1.00 Wisconsin Responsible Opioid Prescribing Credit
    • 1.00 ANCC Pharmacotherapy Contact Hours
  • 1.00 University of Wisconsin–Madison Continuing Education Hours
    • 1.00 Approved for AMA PRA Category 1 Credit™
    • 1.00 Wisconsin Responsible Opioid Prescribing Credit
Registration opens: 
06/29/2026
Course expires: 
06/28/2027
Cost:
$0.00
Rating: 
0

FACULTY DISCLOSURE

It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the  speakers/presenters, authors, planners, and other persons who may influence the content of this accredited continuing education (CE).  In addition, speakers, presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation.

Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on, patients.

The ACCME does not consider providers of clinical services directly to patients to be ineligible companies.

For this accredited continuing educational activity all relevant financial relationships have been mitigated and detailed disclosures are listed below:

NameRoleFinancial Relationship DisclosuresDiscussion of Unlabeled/Unapproved uses of drugs/devices in presentation?
Rachel McMinn, RN, MSN, APNP-BC
Department of Anesthesia
UW Health
Speaker/Author

No relevant relationships with ineligible companies to disclose

No
Laura Sasse, RN
Clinical Nurse Specialist
UW Health
Speaker/AuthorNo relevant relationships with ineligible companies to discloseNo
Amanda Rowe, NP, Chair
Urgent Care
UW Health

RSS Chair

No relevant relationships with ineligible companies to disclose

No

Anna Schmidt, PA, Chair
Ear, Nose and Throat (ENT, Otolaryngology)
UW Health

RSS Chair

No relevant relationships with ineligible companies to disclose

No

Emily Jumper, MS. Ed.
UW Health

RSS Coordinator

No relevant relationships with ineligible companies to disclose

No

Samantha Frame
UW Health
RSS CoordinatorNo relevant relationships with ineligible companies to disclose

No

Jillian Bodden Hoenisch, NP
Geriatrics
UW Health

Planner

No relevant relationships with ineligible companies to disclose

No

Zachary Goldberger, MD
Professor
Cardiovascular Medicine
Department of Medicine
University of Wisconsin School of Medicine and Public Health

Planner

No relevant relationships with ineligible companies to disclose

No

Anna Kunde, CRNA
Anesthesiology
UW Health
PlannerNo relevant relationships with ineligible companies to discloseNo
Kristen Panther, NP
Senior Director of Advanced Practice Providers
UW Health
PlannerNo relevant relationships with ineligible companies to discloseNo
Discloser List CME Internal Report

Accreditation Statement

Jointly Accredited Provider with CommendationIn support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Designation Statements

American Medical Association

The University of Wisconsin–Madison ICEP designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsPhysicians should claim only the credit commensurate with the extent of their participation in the activity.

American Nurses Credentialing Center (ANCC)

The University of Wisconsin–Madison ICEP designates this enduring material for a maximum of 1 ANCC contact hour. 

American Academy of Physician Assistants (AAPA)

The University of Wisconsin–Madison ICEP has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. Approval is valid until 6/28/2027. PAs should only claim credit commensurate with the extent of their participation. 

Wisconsin Medical Examining Board Opioid CME

This course is designed to meet the Wisconsin MEB requirements for continuing education on prescribing opioids and other controlled substances.
Course Title: Rethinking Pain Relief: Multimodal Strategies and Safer Opioid Prescribing for APPs
Number of Credits: 1.0

Medication Access and Training Expansion (MATE) Act 

This course is designed to meet the requirements outlined in the Medication Access and Training Expansion (MATE) Act. (Click here for more information.)
Number of hours: 1.0

Continuing Education Units

The University of Wisconsin–Madison, as a member of the University Continuing Education Association (UCEA), authorizes this program for .1 continuing education units (CEUs) or 1 hour.

Available Credit

  • 1.00 AAPA Category 1 CME
    • 1.00 Wisconsin Responsible Opioid Prescribing Credit
  • 1.00 AMA PRA Category 1 Credit
    • 1.00 Wisconsin Responsible Opioid Prescribing Credit
  • 1.00 ANCC Contact Hours
    • 1.00 Wisconsin Responsible Opioid Prescribing Credit
    • 1.00 ANCC Pharmacotherapy Contact Hours
  • 1.00 University of Wisconsin–Madison Continuing Education Hours
    • 1.00 Approved for AMA PRA Category 1 Credit™
    • 1.00 Wisconsin Responsible Opioid Prescribing Credit

Cost:
$0.00
Please login or register to take this course.

Registration for this activity can only be completed through the ICEP Learning Portal. Attendee registrations made through any other sites cannot be honored. UW-Madison ICEP is not able to refund fees paid through unaffiliated registration sites, such as eMedEvents.com, MedConfWorld.com, EventEgg.com, and 10times.com. Please report any unauthorized websites or solicitations for registrations to [email protected]

Accessibility

If you need anything to participate in this program, please contact [email protected]

Required Hardware/software

Computer, tablet, or other mobile device with sound (closed captioning also available).

Free, current version of Edge, Firefox, Safari, or Chrome. Some older browsers and Internet Explorer could produce error messages or not display the content correctly. 

Free, current version of Adobe Acrobat Reader or other .pdf reader.